Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Accent
2. Glutamate, Sodium
3. Msg
4. Sodium Glutamate
5. Vestin
1. 142-47-2
2. Sodium L-glutamate
3. Sodium Glutamate
4. Ajinomoto
5. Glutacyl
6. L-glutamic Acid, Monosodium Salt
7. Monosodium L-glutamate
8. Glutavene
9. Ancoma
10. L-monosodium Glutamate
11. Chinese Seasoning
12. L-glutamic Acid Monosodium Salt
13. 16177-21-2
14. L-glutamic Acid Sodium Salt
15. Glutamic Acid, Sodium Salt
16. L(+) Sodium Glutamate
17. Glutamate Monosodium Salt
18. Sodium Hydrogen Glutamate
19. Natriumglutaminat
20. Glutamate Sodium
21. Natrium L-hydrogenglutamat
22. Monosodioglutammato
23. Glutammato Monosodico
24. Fema No. 2756
25. Vetsin
26. Zest
27. Sodium (s)-2-amino-4-carboxybutanoate
28. Rl-50
29. Msg
30. Sodium;(2s)-2-amino-5-hydroxy-5-oxopentanoate
31. Monosodium Glutamate Anhydrous
32. Sodium (2s)-2-amino-4-carboxybutanoate
33. L-glutamic Acid Monosodium
34. Accent (food Additive)
35. Glutamat Sodny [czech]
36. Glutamat Sodny
37. Sodium Glutamate (van)
38. Natriumglutaminat [german]
39. C3c196l9fg
40. Sodium L-glutamate (van)
41. Monosodioglutammato [italian]
42. Ccris 3625
43. Hsdb 580
44. Glutammato Monosodico [italian]
45. Mono Sodium Glutamate
46. Glutamic Acid, L-, Sodium Salt
47. L-glutamic Acid, Sodium Salt (1:1)
48. Glutamate Sodium [jan]
49. Einecs 205-538-1
50. L-glutamic Acid, Sodium Salt (van)
51. Nsc 135529
52. Unii-c3c196l9fg
53. Ai3-18393
54. Einecs 240-313-1
55. Glutamic Acid, Monosodium Salt, L-
56. L-glutamic Acid, Sodiumsalt (1:1)
57. H-glu-oh.na
58. 6106-04-3
59. Ec 205-538-1
60. Schembl16336
61. Dtxsid9020906
62. Akos027257231
63. Sodium 2-amino-5-hydroxy-5-oxopentanoate
64. G0188
65. J-007661
| Molecular Weight | 169.11 g/mol |
|---|---|
| Molecular Formula | C5H8NNaO4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 169.03510202 g/mol |
| Monoisotopic Mass | 169.03510202 g/mol |
| Topological Polar Surface Area | 103 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 149 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
One of the FLAVORING AGENTS used to impart a meat-like flavor. Medically it has been used to reduce blood ammonia levels in ammoniacal azotemia, therapy of hepatic coma, in psychosis, and mental retardation.
National Library of Medicine - Medical Subject Headings (2007)
The large doses of sodium glutamate required for the treatment of hepatic encephalopathy may result in dangerous alkalosis and hypokalemia ... important to keep close control on the electrolyte balance during therapy.
Reynolds, J.E.F., Prasad, A.B. (eds.) Martindale-The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982., p. 59
Injections of sodium glutamate should be given with caution to patients with hepatic cirrhosis, impaired renal function, or liver disease not associated with hyperammonemia.
Reynolds, J.E.F., Prasad, A.B. (eds.) Martindale-The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982., p. 59
Food and Environmental Agents: Effect on Breast-Feeding: Monosodium glutamate: None. /from Table 7/
Report of the American Academy of Pediatrics Committee on Drugs in Pediatrics 93 (1): 142 (1994)
Flavoring Agents
Substances added to foods and medicine to improve the taste. (See all compounds classified as Flavoring Agents.)
Glutamate is absorbed from the gut by an active transport system specific for amino acids. This process is saturable, can be competitively inhibited, and is dependent on sodium ion concentration... . During intestinal absorption, a large proportion of glutamic acid is transaminated and consequently alanine levels in portal blood are elevated. If large amounts of glutamate are ingested, portal glutamate levels increase ... . This elevation results in increased hepatic metabolism of glutamate, leading to release of glucose, lactate, glutamine, and other amino acids, into systemic circulation ... . The pharmacokinetics of glutamate depend on whether it is free or incorporated into protein, and on the presence of other food components. Digestion of protein in the intestinal lumen and at the brush border produces a mixture of small peptides and amino acids; di-and tri-peptides may enter the absorptive cells where intracellular hydrolysis may occur, liberating further amino acids. Defects are known in both amino acid and peptide transport ... .. Glutamic acid in dietary protein, together with endogenous protein secreted into the gut, is digested to free amino acids and small peptides, both of which are absorbed into mucosal cells where peptides are hydrolyzed to free amino acids and some of the glutamate is metabolized. Excess glutamate and other amino acids appear in portal blood. As a consequence of the rapid metabolism of glutamate in intestinal mucosal cells and in the liver, systemic plasma levels are low, even after ingestion of large amounts of dietary protein. /Glutamic acid/
WHO Food Additive Series 22; L-Glutamic Acid and its Ammonium, Calcium, Monosodium and Potassium Salts. Available from, as of March 20, 2007: https://www.inchem.org/documents/jecfa/jecmono/v22je12.htm
... Intestinal and hepatic metabolism results in elevation of levels in systemic circulation only after extremely high doses given by gavage (>30mg/kg body weight). Ingestion of monosodium glutamate (MSG) was not associated with elevated levels in maternal milk, and glutamate did not readily pass the placental barrier. Human infants metabolized glutamate similarly to adults.
PMID:10736380 Walker R and Lupien JR; J Nutr 130 (4S Suppl): 1049S-52S (2000)
Oral administration of pharmacologically high doses of glutamate results in elevated plasma levels. The peak plasma glutamate levels are both dose and concentration dependent ... . When the same dose (1 g/kg b.w.) of monosodium glutamate (MSG) was administered by gavage in aqueous solution to neonatal rats, increasing the concentration from 2% to 10% caused a five-fold increase in the plasma area under curve; similar results were observed in mice ... . Conversely, when MSG (1.5 g/kg b.w.) was administered to 43-day-old mice by gavage at varying concentrations of 2 to 20% w/v, no correlation could be established between plasma levels and concentration ...
WHO Food Additive Series 22; L-Glutamic Acid and its Ammonium, Calcium, Monosodium and Potassium Salts. Available from, as of March 20, 2007: https://www.inchem.org/documents/jecfa/jecmono/v22je12.htm
Administration of a standard dose of 1 g/kg b.w. MSG by gavage as a 10% w/v solution resulted in a marked increase of plasma glutamate in all species studied. Peak plasma glutamate levels were lowest in adult monkeys (6 times fasting levels) and highest in mice (12-35 times fasting levels). Age-related differences between neonates and adults were observed; in mice and rats, peak plasma levels and area under curve were higher in infants than in adults while in guinea pigs the converse was observed.
WHO Food Additive Series 22; L-Glutamic Acid and its Ammonium, Calcium, Monosodium and Potassium Salts. Available from, as of March 20, 2007: https://www.inchem.org/documents/jecfa/jecmono/v22je12.htm
For more Absorption, Distribution and Excretion (Complete) data for MONOSODIUM GLUTAMATE (7 total), please visit the HSDB record page.
Glutamic acid is metabolized in the tissues by oxidative deamination ... or by transamination with pyruvate to yield oxaloacetic acid ... which, via alpha-ketoglutarate, enters the citric acid cycle ... .. Quantitatively minor but physiologically important pathways of glutamate metabolism involve decarboxylation to gamma-aminobutyrate (GABA) and amidation to glutamine ... . Decarboxylation to GABA is dependent on pyridoxal phosphate, a coenzyme of glutamic acid decarboxylase ..., as is glutamate transaminase. Vitamin B6-deficient rats have elevated serum glutamate levels and delayed glutamate clearance ... . /Glutamic acid/
WHO Food Additive Series 22; L-Glutamic Acid and its Ammonium, Calcium, Monosodium and Potassium Salts. Available from, as of March 20, 2007: https://www.inchem.org/documents/jecfa/jecmono/v22je12.htm
Oral dose of 1 g/kg monosodium glutamate given to rats was followed by only a small rise in plasma pyroglutamate levels. No incr of pyroglutamate or glutamate brain levels was observed under these conditions.
PMID:7080082 CACCIA S ET AL; TOXICOL LETT 10 (2-3): 169 (1982)
L-Glutamate and GABA supposedly act as excitatory and inhibitory transmitters, respectively, in the central nervous system. Glutamate is also involved in the synthesis of proteins. /Glutamate/
WHO Food Additive Series 22; L-Glutamic Acid and its Ammonium, Calcium, Monosodium and Potassium Salts. Available from, as of March 20, 2007: https://www.inchem.org/documents/jecfa/jecmono/v22je12.htm
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Thickeners and Stabilizers
Coating Systems & Additives
Taste Masking
Parenteral
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
61
PharmaCompass offers a list of Sodium Glutamate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Glutamate manufacturer or Sodium Glutamate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Glutamate manufacturer or Sodium Glutamate supplier.
PharmaCompass also assists you with knowing the Sodium Glutamate API Price utilized in the formulation of products. Sodium Glutamate API Price is not always fixed or binding as the Sodium Glutamate Price is obtained through a variety of data sources. The Sodium Glutamate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ajinomoto manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ajinomoto, including repackagers and relabelers. The FDA regulates Ajinomoto manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ajinomoto API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ajinomoto supplier is an individual or a company that provides Ajinomoto active pharmaceutical ingredient (API) or Ajinomoto finished formulations upon request. The Ajinomoto suppliers may include Ajinomoto API manufacturers, exporters, distributors and traders.
click here to find a list of Ajinomoto suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ajinomoto DMF (Drug Master File) is a document detailing the whole manufacturing process of Ajinomoto active pharmaceutical ingredient (API) in detail. Different forms of Ajinomoto DMFs exist exist since differing nations have different regulations, such as Ajinomoto USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ajinomoto DMF submitted to regulatory agencies in the US is known as a USDMF. Ajinomoto USDMF includes data on Ajinomoto's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ajinomoto USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ajinomoto suppliers with USDMF on PharmaCompass.
Ajinomoto Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ajinomoto GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ajinomoto GMP manufacturer or Ajinomoto GMP API supplier for your needs.
A Ajinomoto CoA (Certificate of Analysis) is a formal document that attests to Ajinomoto's compliance with Ajinomoto specifications and serves as a tool for batch-level quality control.
Ajinomoto CoA mostly includes findings from lab analyses of a specific batch. For each Ajinomoto CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ajinomoto may be tested according to a variety of international standards, such as European Pharmacopoeia (Ajinomoto EP), Ajinomoto JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ajinomoto USP).
